HOUSTON--(BUSINESS WIRE)--The Burzynski Clinic (BC) announced today that it made a presentation of the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in pediatric recurrent diffuse intrinsic pontine glioma (DIPG) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Brainstem gliomas are rare tumors in which DIPG is comprise a distinct group. Numerous trials have been conducted in DIPG without proving pharmacological benefit.
Help employers find you! Check out all the jobs and post your resume.
